
Three Things to Know about the COVID-19 Vaccines
Here are three key takeaways from the December 2 discussion on vaccine development with infectious disease expert and University of Michigan School of Public Health professor Arnold Monto.
We're still accepting applications for fall 2025!
Apply TodayHere are three key takeaways from the December 2 discussion on vaccine development with infectious disease expert and University of Michigan School of Public Health professor Arnold Monto.
As the weather gets colder and we find ourselves inside for longer periods of time, how can we avoid aerosolized droplets becoming a problem for disease transmission in our public buildings? Dr. Aurora Le walks us through some basic steps any building occupant or manager can take to mitigate risk of COVID-19 spread.
Months after they first experienced COVID-19 symptoms, 1 in 4 Michigan residents with a confirmed case of coronavirus had not fully recovered from the illness, according to a joint study that seeks to document Michiganders' experiences with the novel coronavirus.
Black patients are more likely to be hospitalized with COVID-19 than white patients with similar underlying health and socioeconomic conditions, according to a new University of Michigan School of Public Health study.
Arnold Monto, a leading epidemiologist at the University of Michigan's School of Public Health, will serve as acting chair of the Vaccines and Related committee Biological Products Advisory Committee meeting. The committee, which provides advice to the Food and Drug Administration, will discuss the development, authorization and licensure of vaccines to prevent COVID-19.
A group of faculty, staff, and students from the University of Michigan School of Public Health are working with the Michigan State Youth Soccer Association (MSYSA) to get the organization’s over 90,000 youth back on the soccer field during the coronavirus pandemic with the help of public health practices and ingenuity.